• Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

  • Mar 14 2024
  • Length: 9 mins
  • Podcast

Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

Listen for free

View show details

  • Summary

  • In this podcast, Chiara De Biase and Jean Marco highlight three key reasons for Charles Dotter's failure to spread his method widely in the USA. Firstly, his position as a radiologist, not a vascular surgeon; secondly, his aggressive presentation of the technique, coupled with limited patient data; and lastly, his unconventional approach to developing tools and the lack of clear objectives.

    Stay tuned to discover how Dotter's method made its way to Europe in the next episode.


    Hosted on Acast. See acast.com/privacy for more information.
    Show More Show Less
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Transluminal angioplasty: Why was Dotter's disruptive innovation initially rejected?

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available